Showcase series: Attention Deficit Hyperactivity Disorder (ADHD):

Showcase series: Attention Deficit Hyperactivity Disorder (ADHD):

November 23, 2022 1:00 PM to 1:30 PMOnline
Area of Interest: Benefits Format: Web


Attention Deficit Hyperactivity Disorder (ADHD)

A growing mental health trend for group benefits

In this session, Denuja Raventhiran, Senior Pharmaceutical Benefits Strategist, Pharmaceutical Benefits & Innovation at Sun Life will focuss on attention deficit hyperactivity disorder (ADHD, a  growing mental health trend for group benefits. She will also look at drug data and paramedical trends, and review tools and resources that can help organizations. 

Sponsored by 


COST : COMPLIMENTARY 

Dialogue is the leading Canadian virtual care provider that delivers online health and wellness programs dedicated exclusively to organizations who wish to improve the well-being of their members and families. Dialogue's next-generation Integrated Health Platform™ seamlessly connects our primary care, mental health, and EAP programs into one consistent user experience that provides human resources and business leaders with aggregated reporting and easy administration, and members with one app and one login to access all wellness programs supported by our multidisciplinary health and wellness team.

During this 30 minutes presentation, we will share with you a quick overview of our platform, and how it can help improve productivity, reduce absenteeism, and help build an amazing work culture that promotes happiness and well-being. In addition, you’ll hear real testimonials from our team. Don’t miss it.

The CPBI Showcase series is a 30-minutes sponsored demo aimed to offer the series’ participants with pertinent information about available products and services. The CPBI does not endorse any of the products or services presented.

SPEAKER 

Denuja Raventhiran

Denuja Raventhiran
Senior Pharmaceutical Benefits Strategist,
Pharmaceutical Benefits & Innovation

As a Benefits Strategist, Denuja Raventhiran works together with members of the Pharmaceutical Benefits team to support strategy development, acting as a subject matter expert. Together, the team takes part in dedicated efforts that balance access to care and plan sustainability.

Denuja is a pharmacist by profession, currently licensed and practicing in Ontario. She has a background in pharmaceutical marketing strategy through which she brings key clinical insights. She continues to draw from her previous experiences in a range of pharmacy practice and patient care environments.

Denuja holds a Doctorate in Pharmacy from the University of Waterloo and a Bachelor of Science, double major in Medical Science and Biology, from Western University.

By continuing to use this website, you are agreeing to our use of cookies.